Twist Bioscience and Kyowa Kirin Partner for GPCR Antibody Discovery

Twist Bioscience and Biotia Receive U.S. FDA Emergency Use Authorization for First Hybridization Capture-Based Next-Generation Sequencing SARS-CoV-2 Assay

Twist Bioscience Functional GLP-1R Antibodies Identified From Its Proprietary Synthetic DNA GPCR Libraries Demonstrate Potent Blood Glucose Control

Twist Bioscience Begins Shipping of Synthetic RNA Controls for B.1.351 and P.1 Variants

Twist Bioscience Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2021

Twist Bioscience and Watchmaker Genomics Announce Partnership to Drive New Applications of High-throughput Genetic Sequencing

Twist Bioscience to Highlight Genotyping by Sequencing and Methylation Solution During AGBT

Twist Bioscience Launches Industry-Leading NGS Methylation Detection System for Liquid Biopsy Cancer Analysis and Epigenetic Studies

Twist Bioscience and Berry Genomics to Offer New NGS Solution to Advance Research and Precision Medicine

Twist Bioscience to Present at Upcoming Virtual Conferences